Mixed Dyslipidemia
Conditions
Brief summary
An observational study on the identification of prescription patterns of STAFEN Cap., changes in blood lipid concentration, and statin-related muscle symptoms in Korean patients with mixed dyslipidemia
Detailed description
This study aims to observe the effectiveness of STAFEN capsule such as changes in blood lipid concentration and safety including statin-related muscle symptoms, and prescription patterns under daily clinical treatment in patients who have been prescribed STAFEN capsules for the treatment of complex dyslipidemia.
Interventions
None listed
Sponsors
Hanlim Pharm. Co., Ltd.
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Adults over 19 years of age 2. A patient diagnosed with mixed dyslipidemia 3. A patient who was first prescribed a STAFEN cap. for the purpose of treating mixed dyslipidemia according to the clinician's judgment 4. A patient who voluntarily agreed in writing to this study
Exclusion criteria
1. Pregnant women, lactating women, or those planning to conceive 2. A person who is prohibited from administering the STAFEN cap. under the permit 3. If the person in charge of other clinical studies and the person in charge deems it inappropriate to be the subject of this clinical study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Target triglyceride rate at 6 months of STAFEN capsule prescription compared to baseline | at 6 months of STAFEN capsule prescription compared to baseline | Target triglyceride rate at 6 months of STAFEN capsule prescription compared to baseline |
Countries
South Korea
Contacts
Primary ContactHeebaek Park
Outcome results
None listed